Advertisement

PharmacoEconomics & Outcomes News

, Volume 836, Issue 1, pp 16–16 | Cite as

Lesinurad + allopurinol more effective, less costly in Spain

Clinical study
  • 3 Downloads

Reference

  1. Presal M, et al. Second-line treatment with lesinurad and allopurinol versus febuxostat for management of hyperuricemia: a cost-effectiveness analysis for Spanish patients. Clinical Rheumatology : 16 Aug 2019. Available from: URL: https://doi.org/10.1007/s10067-019-04739-3

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations